[Management and prognosis of metastatic ovarian carcinoma from nongenital tract].
OBJECTIVE
To study the management and prognosis of nongenital metastatic ovarian carcinoma.


METHODS
Thirty-four patients with nongenital metastatic ovarian carcinoma who were admitted in to Zhongnan Hospital of Wuhan University between 1998 and 2004 were analyzed retrospectively.


RESULTS
The median survival time of group A (optimal cytoreductive surgery), group B (optimal cytoreductive surgery + chemotherapy), group C (sub-optimal cytoreductive surgery) and group D (sub-optimal cytoreductive surgery + chemotherapy) was 5.0, 10.0, 4.0 and 6.5 months, respectively. The difference was significant between groups A and B, B and C, as well as between group C and D (P < 0.05).


CONCLUSIONS
Most of nongenital metastatic ovarian carcinomas come from tumors of stomach and intestine. Optimal cytoreductive surgery and chemotherapy play an important role in the management and prognosis of nongenital metastatic ovarian carcinoma.
Wu
Xu-feng
XF
Department of Gynecologic Oncology, Zhongnan Hospital, Wuhan University, Wuhan 430071, China.
Chen
Yi
Y
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000473:pathology; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000473:pathology*; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000556:secondary* / Q000601:surgery / Q000628:therapy*; D011379:Prognosis; D012189:Retrospective Studies; D055815:Young Adult